Personalized Genomics and Precision Medicine Explained
This essay examines personalized genomics and precision medicine — technologies designed to tailor pharmaceutical treatments to an individual's genome sequence. Beginning with the biological foundations established by the Human Genome Project, the paper explains how decoding the human genome enables targeted medical interventions. It then surveys the social and ethical considerations surrounding the field, including healthcare cost reduction, improved diagnostic accuracy, pharmacogenetics, and concerns about privacy and discrimination. The essay concludes with a personal assessment of personalized medicine's promise and limitations, arguing that despite current cost and access barriers, the field is poised to become a standard component of modern medical care.
- Introduction to Personalized Medicine: Defines personalized medicine and its origins
- Biological Basis of Genomic Medicine: Explains genomes, SNPs, and targeted interventions
- Social and Ethical Considerations: Covers costs, privacy, and access equity
- Pharmacogenetics and Diagnostic Accuracy: How genomics improves drug treatment and diagnosis
- Personal Viewpoint and Future Outlook: Author's assessment of promise and limitations
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- It moves logically from scientific foundations to social implications to personal evaluation, giving the argument a clear three-part arc that is easy to follow.
- The paper balances optimism about the technology with honest acknowledgment of drawbacks — cost, privacy risk, and unequal access — lending credibility to its conclusions.
- Specific technical vocabulary (SNPs, haplotypes, pharmacogenetics) is introduced and then immediately explained in plain language, making the paper accessible without sacrificing precision.
Key academic technique demonstrated
The paper demonstrates effective use of multiple source types — a government research council, a peer-reviewed journal article, a research laboratory, and a general-audience health publication — to support claims across scientific, policy, and ethical dimensions. This multi-source synthesis signals undergraduate-level research competency.
Structure breakdown
The essay opens with a brief orienting introduction, then develops the biological basis of personalized medicine before widening the lens to social, financial, and ethical considerations. A dedicated section on pharmacogenetics and diagnostic accuracy deepens the analysis before the paper closes with a candid personal viewpoint that weighs benefits against drawbacks. The references follow APA conventions throughout.
Introduction to Personalized Medicine
Personalized genomics and personalized medicine refer to a collection of technologies and techniques designed to custom-tailor pharmaceutical treatments according to a patient's genome sequence. The starting point for personalized medicine — also called "stratified medicine" or "precision medicine" — is the completion of the Human Genome Project (NHMRC, 2014). The Human Genome Project has permitted unprecedented access to genetic information and to the implications that information holds for human health.
Biological Basis of Genomic Medicine
A genome is the entire collection of genes — approximately 23,000 different ones — embedded in each cell of the body (The Jackson Laboratory, 2014). According to Snyder, Du, and Gerstein (2010), determining a genome sequence involves "identifying single-nucleotide polymorphisms [SNPs] and structural variations [SVs], assembling new sequences, and phasing haplotypes" (p. 423). Although only two percent of the human genome is actually comprised of genes themselves, the genome "influences how we look, our genetic predispositions for certain medical conditions, how well our bodies fight disease or metabolize food, and which therapies our bodies do and do not respond to" ("Personalized Medicine," n.d.).
Understanding how to decode the human genome can therefore help biochemists develop targeted interventions based on an individual's unique genetic blueprint. Those interventions can be preventative in nature as well as ameliorative. Biochemists may be able to prepare custom-designed medications that not only target the exact areas of concern, but that are also far superior to general medications in terms of minimizing side effects. Genes may cause some people to experience adverse reactions while others experience none (The Jackson Laboratory, 2014).
Taking into account lifestyle factors, weight, and other variables, personalized medicine may eliminate errors in diagnosis and treatment and promote healing in unprecedented ways. Personalized genomics is, however, still in its infancy. It is not yet possible to sequence a person's entire genome with one hundred percent accuracy, raising important questions about the current feasibility of personalized medicine (Snyder, Du, & Gerstein, 2010).
Social and Ethical Considerations
Personalized medicine is not yet widely available, and although costs have "dramatically" decreased, it remains out of reach for most people (Snyder, Du, & Gerstein, 2010, p. 423). It is a for-profit sector that "already generates $286 billion per year in revenues and is growing by 11% annually" (The Jackson Laboratory, 2014). Personal genome sequencing involves tests and procedures that are both costly and time consuming.
One of the most significant ethical dilemmas associated with personalized medicine concerns privacy, confidentiality, and data security. If personal genome sequencing becomes normative and standardized, some forms of discrimination may become unavoidable. Individuals with genetic predispositions to certain diseases might, for example, be denied access to employment or insurance. Access to medical information as sensitive as an entire genome sequence could also raise serious concerns for many patients.
However, the net social benefits of personalized medicine include a potential long-term reduction in total healthcare costs — including costs associated with loss of life and human suffering. Essentially, personalized medicine shifts the focus to "prevention and prediction of disease rather than reaction to it" ("Personalized Medicine," n.d.). Personalized medicine has the potential to radically transform the paradigm upon which modern medicine is currently based, benefiting patients across the spectrum of conditions from chronic headache to cancer.
References
The Jackson Laboratory. (2014). Personalized medicine and genomics. Retrieved from
"Personalized Medicine." (n.d.). U.S. News and World Report. Retrieved from http://health.usnews.com/health-conditions/cancer/personalized-medicine/overview
National Health and Medical Research Council (NHMRC). (2014). Personalized medicine and genetics. Australian Government. Retrieved from https://www.nhmrc.gov.au/your-health/genetics-and-human-health/genetic-testing-and-applications/personalised-medicine
Snyder, M., Du, J., & Gerstein, M. (2010). Personal genome sequencing: Current approaches and challenges. Genes and Development, 24, 423–431.
Create your account
Always verify citation format against your institution’s current style guide requirements.